Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D).…

Nature - Bites from insects infected with modified malaria parasites boosted immunity and stopped people from contracting the disease.

Lyme borreliosis is caused by Borrelia burgdorferi and related bacteria. It is the most common tick-transmitted illness in the Northern
Hemisphere. The ability of this pathogen to spread to a wide variety of locations
results in a diverse set of clinical…

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 diabetes, according to a new preclinical study. With further testing, the novel approach could one day cure the as-yet incurable condition.

Discovery could open door to game-changing RNA-based multi-cancer therapeutics.

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on other degenerative diseases.

Scientists have discovered a brain circuit that gives pain its emotional sting, explaining why some hurts linger as suffering. The breakthrough challenges our beliefs about how we process pain and may transform chronic pain treatments.

Breakthrough could pave the way for ‘organs on demand’ for patients on the donor waiting list

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug treatments are already approved for use on their own.

Dangerously high levels of “bad” cholesterol and triglycerides may be reduced by gene editing, in what study researchers hope will be a “one and done” treatment.

The Epstein-Barr virus is extremely common and can spread through saliva. 

Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies (bNAbs) can safely stop taking standard, lifelong HIV medications…